Vaccination Destroys SARS Virus, Drug for Severe COVID-19 by Year's End
Researchers have discovered that vaccination can destroy the SARS virus, which caused the 2002-2003 atypical pneumonia epidemic. A study has shown that those infected six months ago have low reinfection rates. Meanwhile, a drug for severely ill COVID-19 patients could be available by the end of the year.
Vaccination has been found to strengthen immunity in those who have already recovered and can neutralize new mutant strains. However, natural infection may provide more comprehensive protection with a wider range of antibodies. A single dose of any vaccine induces neutralizing antibody titers in all donors, making vaccination highly effective.
In a study reported by Pietro Vernazza on August 31, 2025, researchers found that vaccination increased influenza infections among healthcare personnel. Despite this, vaccination is still recommended, as it provides 1000 times more effective virus neutralization than previous infection. Even those who have recovered from COVID-19 should get vaccinated for added protection.
Vaccination has proven to be a powerful tool in the fight against COVID-19, offering strong immunity and protection against reinfection. With a drug for severely ill patients on the horizon, the future of COVID-19 treatment looks promising. However, further research is needed to understand the full implications of vaccination on other infections.
